PACB (STOCKS)
Pacific Biosciences of California, Inc.
$1.160000
+0.050000 (+4.50%)
Prev close: $1.110000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Mark David van Oene
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $359.01M
- Employees
- 575
- P/E (TTM)
- -2.57
- P/B (TTM)
- -10.39
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.14 | $-0.13 | -0.0103 | -7.94% |
|
Mar 2026 (Q1)
|
$-0.12 | $-0.14 | +0.0175 | +12.73% |
|
Dec 2025 (Q4)
|
$-0.12 | $-0.15 | +0.0305 | +20.27% |
|
Sep 2025 (Q3)
|
$-0.13 | $-0.16 | +0.0250 | +16.13% |
Financial Statements
| Revenues | $159.27M |
| Benefits Costs and Expenses | $289.83M |
| Cost Of Revenue | $101.33M |
| Costs And Expenses | $289.83M |
| Gross Profit | $57.95M |
| Operating Expenses | $190.99M |
| Selling, General, and Administrative Expenses | $129.70M |
| Research and Development | $88.36M |
| Operating Income/Loss | -$133.04M |
| Income/Loss From Continuing Operations After Tax | -$131.39M |
| Income/Loss From Continuing Operations Before Tax | -$130.56M |
| Income Tax Expense/Benefit | $827.00K |
| Net Income/Loss | -$131.39M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$131.39M |
| Net Income/Loss Available To Common Stockholders, Basic | -$131.39M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.43 |
| Diluted Earnings Per Share | -$0.43 |
| Basic Average Shares | 609,750,000 |
| Diluted Average Shares | 609,750,000 |
| Assets | $751.85M |
| Current Assets | $338.64M |
| Inventory | $61.08M |
| Other Current Assets | $277.56M |
| Noncurrent Assets | $413.21M |
| Fixed Assets | $26.97M |
| Intangible Assets | $13.08M |
| Other Non-current Assets | $373.16M |
| Liabilities | $785.06M |
| Current Liabilities | $68.81M |
| Accounts Payable | $19.22M |
| Other Current Liabilities | $49.58M |
| Noncurrent Liabilities | $716.26M |
| Equity | -$33.21M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$33.21M |
| Liabilities And Equity | $751.85M |
| Net Cash Flow From Operating Activities | -$118.05M |
| Net Cash Flow From Operating Activities, Continuing | -$118.05M |
| Net Cash Flow From Investing Activities | $120.86M |
| Net Cash Flow From Investing Activities, Continuing | $120.86M |
| Net Cash Flow From Financing Activities | $3.16M |
| Net Cash Flow From Financing Activities, Continuing | $3.16M |
| Net Cash Flow | $5.97M |
| Net Cash Flow, Continuing | $5.97M |
| Comprehensive Income/Loss | -$132.16M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$132.16M |
| Other Comprehensive Income/Loss | -$132.16M |
| Other Comprehensive Income/Loss Attributable To Parent | -$770.00K |